S

Sugi Holdings Co Ltd
TSE:7649

Watchlist Manager
Sugi Holdings Co Ltd
TSE:7649
Watchlist
Price: 3 599 JPY 0.19% Market Closed
Market Cap: 683.8B JPY

Sugi Holdings Co Ltd
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Sugi Holdings Co Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
S
Sugi Holdings Co Ltd
TSE:7649
Operating Income
ÂĄ46B
CAGR 3-Years
13%
CAGR 5-Years
6%
CAGR 10-Years
8%
Sundrug Co Ltd
TSE:9989
Operating Income
ÂĄ46.3B
CAGR 3-Years
10%
CAGR 5-Years
5%
CAGR 10-Years
4%
Tsuruha Holdings Inc
TSE:3391
Operating Income
ÂĄ51.2B
CAGR 3-Years
8%
CAGR 5-Years
2%
CAGR 10-Years
6%
Welcia Holdings Co Ltd
TSE:3141
Operating Income
ÂĄ40.3B
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
11%
MatsukiyoCocokara & Co
TSE:3088
Operating Income
ÂĄ84.6B
CAGR 3-Years
22%
CAGR 5-Years
20%
CAGR 10-Years
15%
Cosmos Pharmaceutical Corp
TSE:3349
Operating Income
ÂĄ40.5B
CAGR 3-Years
10%
CAGR 5-Years
4%
CAGR 10-Years
9%
No Stocks Found

Sugi Holdings Co Ltd
Glance View

Market Cap
651.3B JPY
Industry
Retail

In the bustling realm of Japan's retail sector, Sugi Holdings Co., Ltd. has carved out a formidable presence, quietly steering the ship of healthcare-focused retailing. Established in 1976 and headquartered in Aichi Prefecture, the company operates an extensive network of pharmacies and drugstores under the Sugi Pharmacy, Japan Co., Ltd., and Japan Wellness segments. With its core focus on pharmaceuticals, cosmetics, and daily essentials, Sugi Holdings has adeptly woven itself into the fabric of everyday life for many Japanese consumers. The company strategically places its outlets in residential areas, enabling easy access and convenience, which has proven instrumental in capturing a loyal customer base. Its business model hinges on the dual approach of brick-and-mortar stores complemented by an online presence, where e-commerce facilitates a broader reach while maintaining a personal touch through storefront interactions. The engine that propels Sugi Holdings' revenue generation is its diversified product range, which spans prescription drugs, healthcare products, and an assortment of consumer goods. This diversity orchestrates a steady, reliable cash flow, largely buffered by the recurring nature of pharmaceutical sales. In addition to retail, they offer in-home medical care services, catering to an aging population—a demographic with growing healthcare needs. The company's business acumen is reflected in its adept supply chain management and strategic pricing, which enhance both operational efficiency and competitive positioning. By embracing digital tools and data analytics to better understand consumer behavior, Sugi Holdings continues to refine its offerings, ensuring sustainable growth in a dynamic retail landscape.

Intrinsic Value
3 746.28 JPY
Undervaluation 4%
Intrinsic Value
Price
S

See Also

What is Sugi Holdings Co Ltd's Operating Income?
Operating Income
46B JPY

Based on the financial report for Aug 31, 2025, Sugi Holdings Co Ltd's Operating Income amounts to 46B JPY.

What is Sugi Holdings Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
8%

Over the last year, the Operating Income growth was 16%. The average annual Operating Income growth rates for Sugi Holdings Co Ltd have been 13% over the past three years , 6% over the past five years , and 8% over the past ten years .

Back to Top